Certolizumab pegol (liquid)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Certolizumab pegol (liquid), covering 2020-12-01 to 2020-12-01. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis [Phase 3]